Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.02%||87.96||1.0%||$686.29m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.06%||747.47||2.6%||$489.87m|
|VRTX||Vertex Pharmaceuticals, Inc.||-1.82%||311.81||1.9%||$475.10m|
|BMRN||BioMarin Pharmaceutical, Inc.||-1.27%||102.22||4.2%||$161.73m|
|AXSM||Axsome Therapeutics, Inc.||-2.63%||75.26||1.6%||$141.48m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-6.51%||2.01||0.7%||$140.51m|
|MRTX||Mirati Therapeutics, Inc.||-22.89%||71.52||1.6%||$125.68m|
|HALO||Halozyme Therapeutics, Inc.||0.79%||56.38||18.4%||$81.14m|
|IMGO||Imago BioSciences, Inc.||0.00%||35.86||0.0%||$59.53m|
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01, which is a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1 and TRX518, which is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor, or GITR. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.